Stem Cells, Vol 12, 44-52, Copyright © 1994 by AlphaMed Press

ORIGINAL ARTICLES

Anti-tumorigenic chalcones

S Shibata
Shibata Laboratory of Natural Medicinal Materials, Minophagen Pharmaceutical Company, Tokyo, Japan.

On the basis of our recent findings that licochalcone A isolated from Xin-jiang licorice showed anti-inflammatory and anti-tumorigenic activities, we synthesized more than 40 chalcone derivatives to examine their anti-tumorigenic activities. In vitro inhibitory activity against phosphorylation of phospholipids promoted by tetradecanoylphorbol-13- acetate (TPA) in HeLa cells was adopted as a screening test for anti- tumor-promoting effect. In vivo experimental mouse skin tumors initiated by dimethylbenz[a]-anthracene (DMBA) and promoted by TPA were used to test the anti-tumor-promoting effect of chalcones. In the results, 3'- and 4'-methyl-3-hydroxychalcone showed the highest potency in inhibiting tumorigenesis. They also showed a remarkable inhibitory effect on the proliferation of HGC-27 cells derived from human gastric cancer. We discuss the structure-activity relationship, including stereo-chemical phototransformation, of some chalcone derivatives with reference to their ultraviolet (UV) and nuclear magnetic resonance (NMR) spectroscopic data.

This article has been cited by other articles:

				G. Achanta, A. Modzelewska, L. Feng, S. R. Khan, and P. Huang A Boronic-Chalcone Derivative Exhibits Potent Anticancer Activity through Inhibition of the Proteasome Mol. Pharmacol., July 1, 2006; 70(1): 426 - 433. [Abstract] [Full Text] [PDF]